Literature DB >> 20624096

Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.

Devrim Dundar1, Murat Sayan, Gulden Sonmez Tamer.   

Abstract

The aims of this study were to determine the susceptibilities to macrolide and tetracycline antibiotics and emm type distribution of Streptococcus pyogenes strains isolated in the Kocaeli University Hospital, Turkey. A total of 127 S. pyogenes clinical isolates were tested. Eleven (9%) isolates were resistant to erythromycin, and 23 (18%) isolates were resistant to tetracycline. Ten of the erythromycin-resistant isolates were also resistant to tetracycline. By the triple-disk test, all erythromycin-resistant isolates showed the inducible macrolide-lincosamide-streptogramin-C phenotype and harbored erm(TR) gene. tet(O) was the most common tetracycline resistance gene. Among erythromycin-tetracycline coresistant isolates, seven harbored the tet(O) gene. emm 4, emm 1, emm 2,114, and emm 89 were the most common emm types. These isolates were more susceptible to erythromycin. There was considerable emm type heterogeneity in macrolide or tetracycline resistant isolates. According to our knowledge, this is the first study in which emm type distribution is investigated in Turkey. More comprehensive studies are needed to obtain true information about the epidemiology of macrolide and tetracycline resistance and emm type distribution in Turkey.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624096      PMCID: PMC3124751          DOI: 10.1089/mdr.2010.0021

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  37 in total

1.  High rate of tetracycline resistance in Streptococcus pyogenes in Iran: an epidemiological study.

Authors:  A Jasir; A Tanna; A Noorani; A Mirsalehian; A Efstratiou; C Schalen
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.

Authors:  Andrew C Steer; Irwin Law; Laisiana Matatolu; Bernard W Beall; Jonathan R Carapetis
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

3.  In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.

Authors:  E Giovanetti; M P Montanari; F Marchetti; P E Varaldo
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

4.  Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins.

Authors:  R I Aminov; N Garrigues-Jeanjean; R I Mackie
Journal:  Appl Environ Microbiol       Date:  2001-01       Impact factor: 4.792

5.  Resistance to macrolides in Group A streptococci from the European section of Turkey: genetic and phenotypic characterization.

Authors:  Filiz Akata; Devrim Oztürk; Ozlem Tansel; Müserref Tatman-Otkun; Metin Otkun; Frederic Fitoussi; Edouard Bingen; Murat Tugrul
Journal:  Int J Antimicrob Agents       Date:  2002-12       Impact factor: 5.283

6.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

7.  Presence of the tet(O) gene in erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the mef(A) or the erm(A) gene.

Authors:  Eleonora Giovanetti; Andrea Brenciani; Remo Lupidi; Marilyn C Roberts; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001.

Authors:  Antoaneta Detcheva; Richard R Facklam; Bernard Beall
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

9.  In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.

Authors:  C Betriu; E Culebras; I Rodríguez-Avial; M Gómez; B A Sánchez; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Macrolide resistance determinants of group A streptococci in Ankara, Turkey.

Authors:  Ziya Cibali Acikgoz; Safiye Gocer; Serdar Tuncer
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

View more
  5 in total

1.  ICESp2905, the erm(TR)-tet(O) element of Streptococcus pyogenes, is formed by two independent integrative and conjugative elements.

Authors:  Eleonora Giovanetti; Andrea Brenciani; Erika Tiberi; Alessandro Bacciaglia; Pietro Emanuele Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

2.  Microbiological Features of Upper Respiratory Tract Infections in Bulgarian Children for the Period 1998-2014.

Authors:  Raina Tzvetanova Gergova; Guergana Petrova; Stefan Gergov; Petko Minchev; Ivan Mitov; Tanya Strateva
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

3.  Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.

Authors:  G Soyletir; G Altinkanat; D Gur; B Altun; A Tunger; S Aydemir; C Kayacan; Z Aktas; M Gunaydin; A Karadag; H Gorur; I Morrissey; D Torumkuney
Journal:  J Antimicrob Chemother       Date:  2016-05       Impact factor: 5.790

4.  Characterization of Streptococcus pyogenes from Animal Clinical Specimens, Spain.

Authors:  Ana Isabel Vela; Pilar Villalón; Juan Antonio Sáez-Nieto; Gema Chacón; Lucas Domínguez; José Francisco Fernández-Garayzábal
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

5.  Incidence of macrolide-lincosamide-streptogramin B resistance amongst beta-haemolytic streptococci in The Gambia.

Authors:  Ebenezer Foster-Nyarko; Brenda Kwambana; Fatima Ceesay; Kaddijatou Jawneh; Saffiatou Darboe; Sarah N Mulwa; Buntung Ceesay; Ousman O Secka; Ifedayo Adetifa; Martin Antonio
Journal:  BMC Res Notes       Date:  2017-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.